Results 91 to 100 of about 7,933 (178)

Spatially and genetically distinct African trypanosome virulence variants defined by host interferon-g response [PDF]

, 2007
We describe 2 spatially distinct foci of human African trypansomiasis in eastern Uganda. The Tororo and Soroti foci of <i>Trypanosoma brucei rhodesiense</i> infection were genetically distinct as characterized by 6 microsatellite and 1 ...
Anneli Cooper, Annette MacLeod, Bakhiet M, Bancroft GJ, Cattand P, Hertz CJ, Hunter CA, Jeremy M. Sternberg, Liam Morrison, Lindsay Sweeney, Lorna MacLean, Martin Odiit, Morrison LJ, Page RDM, Peter G. E. Kennedy, Schleifer KW, Schleifer KW, Sternberg JM, Woo PT, World Health Organization   +19 more
core   +1 more source

Microbial‐ and Plant‐Derived Bioactive Peptides and Their Applications against Foodborne Pathogens: Current Status and Future Prospects

International Journal of Microbiology, Volume 2024, Issue 1, 2024.
Bioactive peptides (BAPs) obtained from plants and microbes have been thoroughly explored and studied due to their prophylactic properties. The use of BAPs seems to be a promising substitute for several currently available antibiotics because of their antimicrobial properties against foodborne pathogens.
Anowar Khasru Parvez, Fatema Tuz Jubyda, Mohammed Ayaz, Amily Sarker, Nabila Haque, Md. Shahriar Khan, Taslin Jahan Mou, Md. Atikur Rahman, Md. Amdadul Huq, Giuseppe Comi   +9 more
wiley   +1 more source

Restriction of the alternative pathway of human complement by intact Trypanosoma brucei subsp. gambiense. [PDF]

, 1986
Dana V. Devine, Ronald J. Falk, Andrew E. Balber   +2 more
openalex   +3 more sources

Discovery of mating in the major African livestock pathogen Trypanosoma congolense [PDF]

, 2009
The protozoan parasite, Trypanosoma congolense, is one of the most economically important pathogens of livestock in Africa and, through its impact on cattle health and productivity, has a significant effect on human health and well being.
A MacLeod, A MacLeod, A Tait, A Tait, A Tait, AC Hoare, AL Hughes, Alana Black, Alison Tweedie, AM Schurko, Andreas Schoenefeld, Andy Tait, Annette MacLeod, B Haubold, C. Michael R. Turner, Christiane Hertz-Fowler, CJ Young, D Faye, DK Masiga, DL Hartl, DR Page, F Balloux, FG Razakandrainibe, G Benson, G Evanno, Gina L. Pinchbeck, GL Pinchbeck, J Maynard Smith, J Sternberg, JK Gashumba, JK Pritchard, JR Stevens, JR Stevens, K Lewicka, Laurent Rénia, Liam J. Morrison, LJ Morrison, LJ Morrison, LJ Morrison, M Hope, M Koffi, M Raymond, M Tibayrenc, M Tibayrenc, M Tibayrenc, MA Ramesh, MW Gaunt, NM El-Sayed, P Stenberg, PH Holmes, PMA Shaw, R Peakall, Robert M. Christley, S Geerts, T de Meeus, T Mzilahowa, TJ Anderson, V Jamonneau, W Gibson, W Gibson, W Gibson, W Gibson, W Weir, WP Hedrick   +63 more
core   +3 more sources

Human African Trypanosomiasis Transmission, Kinshasa, Democratic Republic of Congo

Emerging Infectious Diseases, 2006
To investigate the epidemiology of human African trypanosomiasis (sleeping sickness) in Kinshasa, Democratic Republic of Congo, 2 entomologic surveys were conducted in 2005.
Gustave Simo, Philemon Mansinsa Diabakana, Victor Kande Betu Ku Mesu, Emile Zola Manzambi, Gaelle Ollivier, Tazoacha Asonganyi, Gerard Cuny, Pascal Grébaut   +7 more
doaj   +1 more source

The use of Multiple Displacement Amplification to increase the detection and genotyping of Trypanosoma samples immobilised on FTA filters. [PDF]

, 2007
Whole genome amplification methods are a recently developed tool for amplifying DNA from limited template. We report its application in trypanosome infections, characterized by low parasitemias.
Likeufack, A.C.L., MacLeod, A., McCormack, G., Morrison, L.J., Sweeney, L., Tait, A., Truc, P., Turner, C.M.R.   +7 more
core  

Eflornithine is Safer Than Melarsoprol for the Treatment of Second-Stage Trypanosoma Brucei Gambiense Human African Trypanosomiasis. [PDF]

, 2005
Patients with second-stage human African trypanosomiasis treated with eflornithine (n = 251) in 2003 in Kiri, southern Sudan, had an adjusted relative risk of death of 0.2 and experienced significantly fewer cutaneous and neurological adverse effects ...
A. Meussen, Brun, F. Chappuis, K. Stietenroth, Legros, Milord, Milord, N. Udayraj, P. A. Bovier, P  pin, Schmid   +10 more
core   +2 more sources

Variant Surface Glycoprotein gene repertoires in Trypanosoma brucei have diverged to become strain-specific

BMC Genomics, 2007
Background In a mammalian host, the cell surface of African trypanosomes is protected by a monolayer of a single variant surface glycoprotein (VSG). The VSG is central to antigenic variation; one VSG gene is expressed at any one time and there is a low ...
Sharma Reuben, Mott Helen, Jones Nicola G, Picozzi Kim, Hutchinson O Clyde, Welburn Susan C, Carrington Mark   +6 more
doaj   +1 more source

Epidemiology of human African trypanosomiasis

Clinical Epidemiology, 2014
Jose R Franco,1 Pere P Simarro,1 Abdoulaye Diarra,2 Jean G Jannin1 1World Health Organization, Control of Neglected Tropical Diseases, Innovative and Intensified Disease Management, Geneva, Switzerland; 2World Health Organization, Inter Country Support ...
Franco JR, Simarro PP, Diarra A, Jannin JG   +3 more
doaj  

Target product profile: diagnostic test for Trypanosoma brucei gambiense. [PDF]

Bull World Health Organ, 2023
Priotto G, Franco JR, Lejon V, Büscher P, Matovu E, Ndung'u J, Biéler S, Mumba D, Van Reet N, Verlé P, Jamonneau V, Simarro PP, Ebeja AK, Sankara D, Dagne DA.   +14 more
europepmc   +1 more source